Rite Aid (RAD) Stock Rating Upgraded by Vetr
Other analysts also recently issued reports about the company. Evercore ISI began coverage on Rite Aid in a research report on Thursday, January 4th. They set an underperform rating and a $1.50 price target for the company. Loop Capital reissued a hold rating and issued a $2.00 target price (down from $2.50) on shares of Rite Aid in a research report on Friday, September 29th. Royal Bank of Canada set a $2.00 target price on Rite Aid and gave the stock a hold rating in a research report on Wednesday, October 25th. Guggenheim reissued a neutral rating and issued a $2.00 target price on shares of Rite Aid in a research report on Monday, October 2nd. Finally, Zacks Investment Research downgraded Rite Aid from a hold rating to a sell rating in a research report on Tuesday, January 9th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Rite Aid has a consensus rating of Hold and an average price target of $2.75.
Shares of Rite Aid (NYSE RAD) opened at $2.23 on Thursday. The company has a current ratio of 0.86, a quick ratio of 0.59 and a debt-to-equity ratio of 3.66. The company has a market capitalization of $2,369.87, a P/E ratio of 14.87 and a beta of 1.83. Rite Aid has a 52-week low of $1.38 and a 52-week high of $7.23.
ILLEGAL ACTIVITY WARNING: “Rite Aid (RAD) Stock Rating Upgraded by Vetr” was originally published by Watch List News and is the property of of Watch List News. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.watchlistnews.com/rite-aid-rad-stock-rating-upgraded-by-vetr/1825757.html.
Rite Aid Company Profile
Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.
To view Vetr’s full report, visit Vetr’s official website.
Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.